4
Changes in Ownership
Seaport Therapeutics, Inc. Filed Acc 0001193125-26-204471
Chief Scientific Officer acquired 3,351 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Chen Michael Cunyuan · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-04 | Conversion : show line 1 in the form | +3,351 | 3,351 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +63,680 | 63,680 | D |
| 2026-05-04 | Conversion : show line 3 in the form Series B Preferred Stock | −10,526 | 0 | D |
Loading xslF345X06/ownership.xml…